Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Other Accrued Liabilities, Current

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Other Accrued Liabilities, Current

Citius Pharmaceuticals, Inc. (CTXR) had Other Accrued Liabilities, Current of $4.10 million as of 2023-09-30, per its 10-K filed 2023-12-29.

Discontinued › Notes › Payables and Accruals

us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2023-12-29

  • 2023-09-30: Other Accrued Liabilities, Current $4.10M.
  • 2022-09-30: Other Accrued Liabilities, Current $3.69M.
  • 2021-09-30: Other Accrued Liabilities, Current $2.56M.
  • 2020-09-30: Other Accrued Liabilities, Current $1.51M.
Period endOther Accrued Liabilities, Current
2023-09-30$4.10M
10-K · filed 2023-12-29
2022-09-30$3.69M
10-K · filed 2023-12-29
2021-09-30$2.56M
10-K · filed 2022-12-22
2020-09-30$1.51M
10-K · filed 2021-12-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36